← Back to Search

Perio-Healthy for Gum disease

N/A
Waitlist Available
Led By Marcela Rocha de Oliveira Carrilho, DDS, PhD
Research Sponsored by Midwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* (1) 40 years of age or older with a healthy medical history and not meeting any of the
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up october 2024
Awards & highlights

Summary

The swelling of the gum, or periodontitis, is the leading cause for tooth loss, and currently affects up to 65 million adults only in the United States. One of the reasons for the widespread of periodontitis is because currently there are no definitive methods to detect the onset of gum disease. This lack of foresight impedes medical professionals to enact any preventive measures before the disease already manifests itself. We wish to expand our understanding towards the development of periodontitis by studying the expression and activity of salivary markers that have been associated with advanced stages of the disease, wherein the supporting tissues of tooth (periodontium) are already irreversibly destroyed. We hypothesize that a progressive shift in the expression of such salivary markers can indicate a change or evolution of periodontitis staging. In specific, we seek to establish a quantifiable relationship among levels of salivary proteases called MMPs, level of metal ions in different stages varying from health to periodontitis. The overall goal of this proposal is to enhance the predictability of periodontitis, as we are currently unable to diagnose the disease until the manifestation of its clinical signs and symptoms.

Eligible Conditions
  • Gum disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~october 2024
This trial's timeline: 3 weeks for screening, Varies for treatment, and october 2024 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Levels of Metal Ions
Matrix Metalloproteases (MMPs) Salivary Levels
Secondary study objectives
Potential Correlation of MMPs, Metal Ions and Peridontitis Staging

Trial Design

5Treatment groups
Experimental Treatment
Group I: Periodontitis Stage IVExperimental Treatment1 Intervention
Individuals included in this cohort, other than meet the eligibility criteria, should present clinical sign of periodontal defined as Stage IV according to the American Academy of Periodontology. We anticipate low to moderate number of participants in this cohort. No interventions are anticipated.
Group II: Periodontitis Stage IIIExperimental Treatment1 Intervention
Individuals included in this cohort, other than meet the eligibility criteria, should present clinical sign of periodontal defined as Stage III according to the American Academy of Periodontology. We anticipate moderate to high number of participants in this cohort. No interventions are anticipated.
Group III: Periodontitis Stage IIExperimental Treatment1 Intervention
Individuals included in this cohort, other than meet the eligibility criteria, should present clinical sign of periodontal defined as Stage II according to the American Academy of Periodontology. We anticipate a moderate number of participants in this cohort. No interventions are anticipated.
Group IV: Periodontitis Stage IExperimental Treatment1 Intervention
Individuals included in this cohort, other than meet the eligibility criteria, should present clinical sign of periodontal defined as Stage I according to the American Academy of Periodontology. We anticipate low to moderate number of participants in this cohort. No interventions are anticipated.
Group V: Perio-HealthyExperimental Treatment1 Intervention
Individuals included in this cohort, other than meet the eligibility criteria, should present no clinical sign of periodontal disease. We anticipate to find from a very small number to none participants at this cohort. No intervention are anticipated.

Find a Location

Who is running the clinical trial?

Midwestern UniversityLead Sponsor
20 Previous Clinical Trials
3,442 Total Patients Enrolled
Marcela Rocha de Oliveira Carrilho, DDS, PhDPrincipal InvestigatorMidwestern University
~52 spots leftby Sep 2025